Suppr超能文献

Identification of a novel orally bioavailable phosphodiesterase 10A (PDE10A) inhibitor with efficacy in animal models of schizophrenia.

作者信息

Bartolomé-Nebreda José Manuel, Alonso de Diego Sergio A, Artola Marta, Delgado Francisca, Delgado Óscar, Martín-Martín María Luz, Martínez-Viturro Carlos M, Pena Miguel Ángel, Tong Han Min, Van Gool Michiel, Alonso José Manuel, Fontana Alberto, Macdonald Gregor J, Megens Anton, Langlois Xavier, Somers Marijke, Vanhoof Greet, Conde-Ceide Susana

机构信息

Neuroscience Medicinal Chemistry and ‡Discovery Sciences Analytical Chemistry, Janssen Research & Development , Calle Jarama 75, Polígono Industrial, Toledo 45007, Spain.

出版信息

J Med Chem. 2015 Jan 22;58(2):978-93. doi: 10.1021/jm501651a. Epub 2015 Jan 12.

Abstract

We report the continuation of a focused medicinal chemistry program aimed to further optimize a series of imidazo[1,2-a]pyrazines as a novel class of potent and selective phosphodiesterase 10A (PDE10A) inhibitors. In vitro and in vivo pharmacokinetic and pharmacodynamic evaluation allowed the selection of compound 25a for its assessment in preclinical models of psychosis. The evolution of our medicinal chemistry program, structure-activity relationship (SAR) analysis, as well as a detailed pharmacological profile for optimized lead 25a are described.

摘要

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验